CV Lattes
ORCID
Abstract
The response to initial therapy is an excellent tool for monitoring papillary thyroid carcinomas (PTC) and uses, among other tests, serum thyroglobulin (Tg) measurement, the main marker for detecting persistence/recurrence of the disease. Although the Tg measurement is sensitized by the presence of high TSH concentration, still isn't clear if the response of initial therapy is best rated …